Condition
Stage II Prostate Adenocarcinoma AJCC v7
ClinicalTrials.gov condition label
Clinical trials
8 shownStereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone SurgeryNCT03541850 · 2019-01-29
ACTIVE_NOT_RECRUITINGStereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate CancerNCT03367702 · 2018-02-01
ACTIVE_NOT_RECRUITINGHypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate CancerNCT03274687 · 2017-07-28
COMPLETEDAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryNCT03070886 · 2017-04-05
ACTIVE_NOT_RECRUITINGStereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryNCT02830165 · 2016-06-15
COMPLETEDPROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active SurveillanceNCT02326805 · 2015-06-03
COMPLETEDItraconazole in Treating Patients With Biochemically Relapsed Prostate CancerNCT01787331 · 2013-10-29
COMPLETEDHypofractionated Proton Beam Therapy for Localized Prostate CancerNCT01950351 · 2013-10-10
ACTIVE_NOT_RECRUITINGCommon interventions
Laboratory Biomarker AnalysisOTHER6Quality-of-Life AssessmentOTHER5Stereotactic Body Radiation TherapyRADIATION3Antiandrogen TherapyDRUG1BicalutamideDRUG1DegarelixDRUG1DocetaxelDRUG1External Beam Radiation TherapyRADIATION1FlutamideDRUG1GoserelinDRUG1Goserelin AcetateDRUG1Hypofractionated Radiation TherapyRADIATION1Intensity-Modulated Radiation TherapyRADIATION1ItraconazoleDRUG1LeuprolideDRUG1Leuprolide AcetateDRUG1NilutamideDRUG1Pharmacological StudyOTHER1Placebo AdministrationOTHER1Proton Beam Radiation TherapyRADIATION1Questionnaire AdministrationOTHER1Radiation TherapyRADIATION1Rilimogene GalvacirepvecBIOLOGICAL1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING4
COMPLETED4
Phase mix
PHASE25
PHASE33
NA1
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.